Search filters

List of works by Sandor Fritsch

A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals ⬇️

scientific article published on January 19, 2012

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

scientific article

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

scientific article

A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory

scientific article published on July 28, 2012

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.

scientific article published on June 2012

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

scientific article

Clinical development of a Vero cell culture-derived seasonal influenza vaccine ⬇️

scientific article published on December 13, 2011

Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine

scientific article published on 7 May 2010

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

scientific article published on 28 April 2010

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

scientific article published on 17 May 2006

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial ⬇️

scientific article published on February 15, 2011

Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.

scientific article

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

scientific article

Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.

scientific article published on 16 August 2011

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity ⬇️

scientific article published on December 12, 2003

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

scientific article published on 10 May 2013

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

scientific article

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial

scientific article published on 12 October 2011

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine

scientific article

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years

scientific article published on August 2009

Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants

scientific article published on 11 May 2013

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

scientific article published on January 2003

Paulina is supported by:

About Paulina

Help